Zobrazeno 1 - 10
of 520
pro vyhledávání: '"Mastelic-Gavillet B"'
Autor:
Mastelic-Gavillet, B., Sarivalasis, A., Lozano, L.E., Lofek, S., Wyss, T., Melero, I., de Vries, IJM, Harari, A., Romero, P., Kandalaft, L.E., Viganó, S.
Publikováno v:
Frontiers in immunology, vol. 14, pp. 1119371
Frontiers in Immunology, 14
Frontiers in Immunology, 14
BackgroundThe use of circulating cDC1 to generate anti-cancer vaccines is among the most promising approaches to overcome the limited immunogenicity and clinical efficacy of monocyte-derived DC. However, the recurrent lymphopenia and the reduction of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75c7ba051339c604d73a1532843207bf
https://doi.org/10.3389/fimmu.2023.1119371
https://doi.org/10.3389/fimmu.2023.1119371
Autor:
Ahmed R; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Lozano LE; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Anastasio A; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Lofek S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Mastelic-Gavillet B; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Navarro Rodrigo B; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Nguyen S; Urology Research Unit and Urology Biobank, Department of Urology, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Dartiguenave F; Urology Research Unit and Urology Biobank, Department of Urology, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Rodrigues-Dias SC; Urology Research Unit and Urology Biobank, Department of Urology, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Cesson V; Urology Research Unit and Urology Biobank, Department of Urology, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Valério M; Urology Research Unit and Urology Biobank, Department of Urology, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Roth B; Urology Research Unit and Urology Biobank, Department of Urology, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Kandalaft LE; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Redchenko I; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford OX3 7BN, UK., Hill AVS; Nuffield Department of Medicine, The Jenner Institute, Oxford University, Oxford OX3 7BN, UK., Harari A; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Romero P; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Derré L; Urology Research Unit and Urology Biobank, Department of Urology, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland., Viganó S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.; Ludwig Institute for Cancer Research, University Hospital of Lausanne, CH-1011 Lausanne, Switzerland.
Publikováno v:
Cancers [Cancers (Basel)] 2023 Jun 08; Vol. 15 (12). Date of Electronic Publication: 2023 Jun 08.
Autor:
Vono M; Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Mastelic-Gavillet B; Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Mohr E; Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Östensson M; Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden., Persson J; Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden., Olafsdottir TA; Faculty of Medicine, Biomedical Center, University of Iceland, Reykjavik, Iceland., Lemeille S; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Pejoski D; Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Hartley O; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Christensen D; Vaccine Adjuvant Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Andersen P; Vaccine Adjuvant Research, Department of Infectious Disease Immunology, Statens Serum Institut, Copenhagen, Denmark., Didierlaurent AM; Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Harandi AM; Department of Microbiology and Immunology, University of Gothenburg, Gothenburg, Sweden.; Vaccine Evaluation Center, British Columbia (BC) Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada., Lambert PH; Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Siegrist CA; Center for Vaccine Immunology, Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Mar 31; Vol. 14, pp. 1155200. Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).
Publikováno v:
Frontiers in immunology, vol. 10, pp. 766
With the advent of combined immunotherapies, personalized dendritic cell (DC)-based vaccination could integrate the current standard of care for the treatment of a large variety of tumors. Due to their proficiency at antigen presentation, DC are key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1900::f62be0d2027f49a1c75551c668085f3c
https://serval.unil.ch/resource/serval:BIB_D40F225C7046.P001/REF.pdf
https://serval.unil.ch/resource/serval:BIB_D40F225C7046.P001/REF.pdf
Autor:
Wang, Jing1 (AUTHOR) wwangjing0405@163.com, He, Yuanli1 (AUTHOR), Hu, Feiming1 (AUTHOR), Hu, Chenchen1 (AUTHOR), Sun, Yuanjie1 (AUTHOR), Yang, Kun1 (AUTHOR) yangkunkun@fmmu.edu.cn, Yang, Shuya1 (AUTHOR) yangkunkun@fmmu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 22, p12223. 18p.
Autor:
Auderset F; World Health Organization Collaborating Center for Vaccine Immunology, Departments of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland., Belnoue E; World Health Organization Collaborating Center for Vaccine Immunology, Departments of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland., Mastelic-Gavillet B; World Health Organization Collaborating Center for Vaccine Immunology, Departments of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland., Lambert PH; World Health Organization Collaborating Center for Vaccine Immunology, Departments of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland., Siegrist CA; World Health Organization Collaborating Center for Vaccine Immunology, Departments of Pathology-Immunology and Pediatrics, University of Geneva, Geneva, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Nov 11; Vol. 11, pp. 580974. Date of Electronic Publication: 2020 Nov 11 (Print Publication: 2020).
Autor:
Mastelic-Gavillet B; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Sarivalasis A; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland., Lozano LE; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Wyss T; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland; Bioinformatics Core Facility, Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland., Inoges S; Division of Immunology and Immunotherapy, Center for Applied Medical Researckh, University of Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain; University Clinic, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain., de Vries IJM; Department of Tumour Immunology, Radboud Institute of Molecular Life Sciences, Geert Grooteplein 26-28, 6525 GA, Nijmegen, the Netherlands; Department of Medical Oncology, Radboudumc, Geert Grooteplein Zuid 10, 6525, GA, Nijmegen, the Netherlands., Dartiguenave F; Urology Research Unit, Department of Urology, CHUV, Switzerland., Jichlinski P; Urology Research Unit, Department of Urology, CHUV, Switzerland., Derrè L; Urology Research Unit, Department of Urology, CHUV, Switzerland., Coukos G; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Melero I; Division of Immunology and Immunotherapy, Center for Applied Medical Researckh, University of Navarra, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain; University Clinic, University of Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red Cáncer, Madrid, Spain., Harari A; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Romero P; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland., Viganó S; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. Electronic address: selena.vigano@chuv.ch., Kandalaft LE; Department of Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Ludwig Institute for Cancer Research, University of Lausanne, Lausanne, Switzerland. Electronic address: lana.kandalaft@chuv.ch.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Aug; Vol. 135, pp. 173-182. Date of Electronic Publication: 2020 Jun 23.
Autor:
Ercolano G; Department of Oncology UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland., Garcia-Garijo A; Tumor Immunology and Immunotherapy, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Salomé B; Precision Immunology Institute, Tisch Cancer Institute, Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York., Gomez-Cadena A; Department of Oncology UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland., Vanoni G; Department of Oncology UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland., Mastelic-Gavillet B; Center for Experimental Therapeutics, Ludwig Center for Cancer Research, Department of Oncology, University of Lausanne, Lausanne, Switzerland., Ianaro A; Department of Pharmacy, University of Naples Federico II, Naples, Italy., Speiser DE; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland., Romero P; Department of Oncology UNIL CHUV, University of Lausanne, Lausanne, Switzerland., Trabanelli S; Department of Oncology UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland., Jandus C; Department of Oncology UNIL CHUV and Ludwig Institute for Cancer Research Lausanne, University of Lausanne, Lausanne, Switzerland. Camilla.jandus@gmail.com.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2020 Apr; Vol. 8 (4), pp. 556-564. Date of Electronic Publication: 2020 Feb 04.
Autor:
Van Kerkhove, Olivier1 (AUTHOR), Verfaillie, Saartje1 (AUTHOR), Maes, Brigitte2,3 (AUTHOR), Cuppens, Kristof1,3 (AUTHOR) kristof.cuppens@jessazh.be
Publikováno v:
Cancers. Sep2024, Vol. 16 Issue 18, p3142. 22p.
Autor:
Choi, Woo Seon1 (AUTHOR), Kwon, Hyung‐Joon1 (AUTHOR), Yi, Eunbi1 (AUTHOR), Lee, Haeun1 (AUTHOR), Kim, Jung Min1 (AUTHOR), Park, Hyo Jin1 (AUTHOR), Choi, Eun Ji2 (AUTHOR), Choi, Myoung Eun2 (AUTHOR), Sung, Young Hoon3 (AUTHOR), Won, Chong Hyun2 (AUTHOR), Sung, Chang Ohk4 (AUTHOR) co.sung@amc.seoul.kr, Kim, Hun Sik1 (AUTHOR) hunkim@amc.seoul.kr
Publikováno v:
Advanced Science. 8/7/2024, Vol. 11 Issue 29, p1-23. 23p.